Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Foghorn Therapeutics
100 Binney Street, Suite 610
Cambridge, MA 02142
Phone: 617-586-3100
http://www.foghorntx.com/

A Flagship Pioneering company, Foghorn was founded in 2016 by Cigall Kadoch, Ph.D., Gerald Crabtree, M.D., and Douglas Cole, M.D., of Flagship Pioneering. With Gene Traffic Control™, Foghorn is pioneering a new major class of drug targets to develop unprecedented therapies for cancer and other serious diseases. Foghorn has a broad platform based on the fundamental biology of Gene Traffic Control. With this powerful platform, Foghorn has already developed new insights, rapidly advanced six programs, and created a discovery engine that will simultaneously yield many additional targets. With insights from Foghorn's scientific founders, seasoned board and leadership team, and discovery engine, this is only the beginning of an entirely new approach to controlling gene expression.

Key Contact
Name
Adrian Gottschalk
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
03/14/18 $50,000,000 Flagship Pioneering
undisclosed